Comparison of Outcomes in Patients With Versus Without Diabetes Mellitus After Revascularization With Everolimus- and Sirolimus-Eluting Stents (from the.

Slides:

Advertisements

Similar presentations

SORT-OUT III: A Prospective Randomized Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease Michael.

Advertisements

Randomized Comparison of Provisional Side Branch Stenting versus a Two-stent Strategy for treatment of True Coronary Bifurcation Lesions Involving a Large.

A Prospective, Randomized, "All-Comers" Trial of Biodegradable Polymer-Coated Biolimus-Eluting Stents vs. Biocompatible Polymer-Coated Zotarolimus-Eluting.

SORT-OUT III: A Prospective Randomized Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease Jens Flensted.

Lisette Okkels Jensen, Per Thayssen, Henrik Steen Hansen, Evald Høj Christiansen, Hans Henrik Tilsted, Lars Romer Krusell, Anton Boel Villadsen, Anders.

TLR Funnel plot (according to outcomes) for studies included in the meta-analysis Death A TVR B MACE DC SE(log OR)

Usefulness of Platelet Response to Clopidogrel by Point-of-Care Testing to Predict Bleeding Outcomes in Patients Undergoing Percutaneous Coronary Intervention.

Influence of a Pressure Gradient Distal to Implanted Bare-Metal Stent on In-Stent Restenosis After Percutaneous Coronary Intervention Lisette Okkels Jensen,

The Third DANish Study of Optimal Acute Treatment of Patients with ST-segment Elevation Myocardial Infarction: DEFERred stent implantation in connection.

Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Randomized Trial of Paclitaxel- Versus Sirolimus-Eluting.

Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Relationship between heparin anticoagulation and.

Date of download: 9/16/2016 Copyright © The American College of Cardiology. All rights reserved. From: 5-Year Clinical Outcomes of the ARTS II (Arterial.

Evaluation of XIENCE V Everolimus-Eluting and Taxus Express2 Paclitaxel-Eluting Coronary Stents in Patients With Jailed Side Branches From the SPIRIT.

Comparison of Low Versus High (>40 mm Hg) Pulse Pressure to Predict the Benefit of Cardiac Resynchronization Therapy for Heart Failure (from the Multicenter.

Meta-Analysis of Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis Ashok.

Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated.

Trends in Outcomes of Revascularization for Left Main Coronary Disease or Three- Vessel Disease With the Routine Incorporation of Fractional Flow Reserve.

SORT-OUT VI A Prospective Randomized Trial of a Durable-Polymer Zotarolimus-Eluting Stent Versus a Bioabsorbable-Polymer Biolimus-Eluting Stent in Patients.

Outcome of Noncardiac and Nonvascular Surgery in Patients With Mechanical Heart Valves Murat Biteker, MD, Ahmet İlker Tekkeşin, MD, Mehmet Mustafa Can,

Usefulness of Preprocedure High-Sensitivity C-Reactive Protein to Predict Death, Recurrent Myocardial Infarction, and Stent Thrombosis According to Stent.

American Heart Journal

Current Problems in Cardiology

Impact of Co-morbidity on the Risk of First-Time Myocardial Infarction, Stroke, or Death After Single-Photon Emission Computed Tomography Myocardial Perfusion.

Frequency of Left Ventricular Thrombus in Patients With Anterior Wall Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention and.

Influence of Diabetes Mellitus on Clinical Outcomes Following Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial.

The Extent of Myocardial Injury During Prolonged Targeted Temperature Management After Out-of-Hospital Cardiac Arrest Anders Morten Grejs, MD, Jakob.

Impact of COPD on Outcome Among Patients With Complicated Peptic Ulcer

Graft patency after off-pump coronary artery bypass surgery is inferior even with identical heparinization protocols: Results from the Danish On-pump.

Volume 54, Issue 1, Pages (August 2009)

Meta-Analysis of Three Randomized Trials and Nine Observational Studies Comparing Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Unprotected.

Meta-analysis of minimally invasive coronary artery bypass versus drug-eluting stents for isolated left anterior descending coronary artery disease Ralf.

Mortality Rate in Type 2 Myocardial Infarction: Observations from an Unselected Hospital Cohort Lotte Saaby, MD, Tina Svenstrup Poulsen, MD, PhD, Axel.

Effects of structured care by a pharmacist-diabetes specialist team in patients with Type 2 diabetic nephropathy Wilson Y.S. Leung, BPharm, PhD, Wing-Yee.

Does Diabetes Mellitus Abolish the Beneficial Effect of Primary Coronary Angioplasty on Long-term Risk of Reinfarction After Acute ST-Segment Elevation.

Effect of Long-Term Endurance and Strength Training on Metabolic Control and Arterial Elasticity in Patients With Type 2 Diabetes Mellitus Antti Loimaala,

Moderate Pulmonary Embolism Treated With Thrombolysis (from the “MOPETT” Trial) Mohsen Sharifi, MD, Curt Bay, PhD, Laura Skrocki, DO, Farnoosh Rahimi,

Long-term clinical outcome of elderly patients with acute coronary syndrome treated with early percutaneous coronary intervention: Insights from the BASE.

Comparison of Bare-Metal Stents and Drug-Eluting Stents in Coronary Ostial Lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry)

Contribution of Three-Dimensional Transesophageal Echocardiography to Diagnosis and Management of Thrombosis of a St. Jude Mechanical Prosthesis in the.

Alfred A. Bartolucci, PhD, Michal Tendera, MD, George Howard, DrPH

Two-Year Clinical Outcomes After Enhanced External Counterpulsation (EECP) Therapy in Patients With Refractory Angina Pectoris and Left Ventricular Dysfunction.

Three Years Follow Up. SORT OUT II

Circ Cardiovasc Interv

A Randomized Trial Comparing a Polymer-Free Coronary Drug-Eluting Stent With an Ultra-Thin Strut Bioresorbable Polymer-Based Drug-Eluting Stent in an All-Comers.

Percutaneous coronary invervention versus coronary artery bypass grafting: A meta- analysis Yolba Smit, MD, MSc, Joan Vlayen, MD, Hetty Koppenaal, MD,

Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction Stein Ørn, MD, John G.F. Cleland, MD, Matti.

Meta-analysis of minimally invasive coronary artery bypass versus drug-eluting stents for isolated left anterior descending coronary artery disease Ralf.

Introduction The American Journal of Medicine

Standardizing definitions for hybrid coronary revascularization

Bypass Versus Drug-Eluting Stents at Three Years in SYNTAX Patients With Diabetes Mellitus or Metabolic Syndrome Michael J. Mack, MD, Adrian P. Banning,

Safety and efficacy of everolimus-eluting bioresorbable vascular scaffolds versus durable polymer everolimus-eluting metallic stents assessed at 1-year.

The Extent of Myocardial Injury During Prolonged Targeted Temperature Management After Out-of-Hospital Cardiac Arrest Anders Morten Grejs, MD, Jakob.

Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies Hisato Takagi,

Coronary Artery Bypass Grafting Versus Coronary Implantation of Sirolimus-Eluting Stents in Patients with Diabetic Retinopathy Takayuki Ohno, MD, Shinichi.

A Randomized Trial Comparing a Polymer-Free Coronary Drug-Eluting Stent With an Ultra-Thin Strut Bioresorbable Polymer-Based Drug-Eluting Stent in an All-Comers.

Large-Scale Registry Examining Safety and Effectiveness of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease Western.

For the Nordic-Baltic PCI Study Group

SORT-OUT III: A Prospective Randomized Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease Michael.

Long-term safety and efficacy of zotarolimus-eluting and sirolimus-eluting stents in routine clinical care patients 36-month follow-up in the SORT OUT.

Graft patency after off-pump coronary artery bypass surgery is inferior even with identical heparinization protocols: Results from the Danish On-pump.

Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Takuya Umemoto, MD, PhD

Do the EXCEL and NOBLE Trial Results Change Meta-Analysis Findings?

Yader Sandoval, MD, Stephen W. Smith, MD, Sara A

Pulse pressure for selecting the optimal cardiac strategy in patients with type 2 diabetes and coronary artery disease Tetsuro Tsujimoto, Hiroshi Kajio

Mortality Rate in Type 2 Myocardial Infarction: Observations from an Unselected Hospital Cohort Lotte Saaby, MD, Tina Svenstrup Poulsen, MD, PhD, Axel.

John-Michael Gamble, BScPharm, MSc, Dean T. Eurich, PhD, Thomas J

Stent Versus Off-Pump Coronary Bypass Grafting in the Second-Generation Drug- Eluting Stent Era Gijong Yi, MD, PhD, Hyun-Chel Joo, MD, Young-Nam Youn,

IVUS-XPL Trial design: Patients undergoing drug-eluting stent implantation for long coronary lesions were randomized to IVUS-guided PCI (n = 700) vs. angiography-guided.

Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization Paul Kurlansky, MD, Morley Herbert, PhD, Syma.

Effects of structured care by a pharmacist-diabetes specialist team in patients with Type 2 diabetic nephropathy Wilson Y.S. Leung, BPharm, PhD, Wing-Yee.

Presentation transcript:

Comparison of Outcomes in Patients With Versus Without Diabetes Mellitus After Revascularization With Everolimus- and Sirolimus-Eluting Stents (from the SORT OUT IV Trial) Lisette Okkels Jensen, MD, DMSci, PhD, Per Thayssen, MD, DMSci, Anders Junker, MD, PhD, Michael Maeng, MD, PhD, Hans-Henrik Tilsted, MD, Anne Kaltoft, MD, PhD, Knud Nørregaard Hansen, MD, Evald Høj Christiansen, MD, PhD, Steen Dalby Kristensen, MD, DMSci, Jan Ravkilde, MD, DMSci, Morten Madsen, MSc, Henrik Toft Sørensen, MD, DMSci, PhD, Leif Thuesen, MD, DMSci, Jens Flensted Lassen, MD, PhD American Journal of Cardiology Volume 110, Issue 11, Pages 1585-1591 (December 2012) DOI: 10.1016/j.amjcard.2012.07.022 Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 1 Time-to-event curves for major adverse cardiac events (composite of cardiac death, myocardial infarction, definite stent thrombosis, and target vessel revascularization) in patients (A) with and without diabetes, (B) with diabetes after implantation of everolimus-eluting or sirolimus-eluting stents, and (C) without diabetes after implantation of everolimus-eluting or sirolimus-eluting stents. American Journal of Cardiology 2012 110, 1585-1591DOI: (10.1016/j.amjcard.2012.07.022) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 2 Time-to-event curves for target lesion revascularization in patients (A) with and without diabetes, (B) with diabetes after implantation of everolimus-eluting or sirolimus-eluting stents, and (C) without diabetes after implantation of everolimus-eluting or sirolimus-eluting stents. American Journal of Cardiology 2012 110, 1585-1591DOI: (10.1016/j.amjcard.2012.07.022) Copyright © 2012 Elsevier Inc. Terms and Conditions